Literature DB >> 35755222

An Overview of La Crosse Virus Disease.

Elizabeth Matthews1, Lakshmi Chauhan1, Amanda L Piquet1, Kenneth L Tyler1,2, Daniel M Pastula1,3.   

Abstract

Entities:  

Keywords:  California serogroup; La Crosse virus; Orthobunyavirus; arbovirus; encephalitis; meningitis; mosquito; pediatric

Year:  2022        PMID： 35755222      PMCID： PMC9214940          DOI： 10.1177/19418744221077738

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN： 1941-8744


× No keyword cloud information.
  12 in total

1.  DNA vaccination against La Crosse virus.

Authors:  J Pavlovic; J Schultz; H P Hefti; T Schuh; K Mölling
Journal:  Intervirology       Date:  2000       Impact factor: 1.763

2.  ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.

Authors:  W H THOMPSON; B KALFAYAN; R O ANSLOW
Journal:  Am J Epidemiol       Date:  1965-03       Impact factor: 4.897

3.  A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.

Authors:  R S Bennett; A K Gresko; J T Nelson; B R Murphy; S S Whitehead
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  La Crosse encephalitis in children.

Authors:  J E McJunkin; E C de los Reyes; J E Irazuzta; M J Caceres; R R Khan; L L Minnich; K D Fu; G D Lovett; T Tsai; A Thompson
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

5.  DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.

Authors:  T Schuh; J Schultz; K Moelling; J Pavlovic
Journal:  Hum Gene Ther       Date:  1999-07-01       Impact factor: 5.695

6.  Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neurons.

Authors:  Durbadal Ojha; Clayton W Winkler; Jacqueline M Leung; Tyson A Woods; Catherine Z Chen; Vinod Nair; Katherine Taylor; Charles D Yeh; Gregory J Tawa; Charles L Larson; Wei Zheng; Cathryn L Haigh; Karin E Peterson
Journal:  Nat Microbiol       Date:  2021-10-21       Impact factor: 17.745

7.  Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening.

Authors:  Zachary J Sandler; Mason R Firpo; Oreoluwa S Omoba; Michelle N Vu; Vineet D Menachery; Bryan C Mounce
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

8.  Age influences susceptibility of brain capillary endothelial cells to La Crosse virus infection and cell death.

Authors:  Rahul Basu; Vinod Nair; Clayton W Winkler; Tyson A Woods; Iain D C Fraser; Karin E Peterson
Journal:  J Neuroinflammation       Date:  2021-06-03       Impact factor: 8.322

9.  La Crosse Virus Disease in the United States, 2003-2019.

Authors:  Grace M Vahey; Nicole P Lindsey; J Erin Staples; Susan L Hills
Journal:  Am J Trop Med Hyg       Date:  2021-07-19       Impact factor: 3.707

Review 10.  Throw out the Map: Neuropathogenesis of the Globally Expanding California Serogroup of Orthobunyaviruses.

Authors:  Alyssa B Evans; Karin E Peterson
Journal:  Viruses       Date:  2019-08-29       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.